Wuguo Deng Selected Research

Nuclear Receptor Coactivator 3

11/2020	Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma.
1/2018	MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wuguo Deng Research Topics

Disease

61	Neoplasms (Cancer) 03/2022 - 07/2007
22	Lung Neoplasms (Lung Cancer) 11/2021 - 07/2007
12	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2014
12	Nasopharyngeal Carcinoma 08/2017 - 01/2012
11	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2011
10	Adenocarcinoma of Lung 01/2021 - 01/2013
8	Melanoma (Melanoma, Malignant) 01/2021 - 01/2013
6	Carcinogenesis 03/2022 - 10/2014
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2013
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 07/2007
4	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2017
4	Carcinoma (Carcinomatosis) 10/2020 - 06/2014
3	Adenocarcinoma 01/2021 - 01/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020 - 01/2016
3	Inflammation (Inflammations) 11/2014 - 01/2011
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 06/2014
2	Leukemia 01/2019 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022
1	Glioma (Gliomas) 12/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Laryngeal Neoplasms (Laryngeal Cancer) 10/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Genetic Translocation (Chromosomal Translocation) 01/2020

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2007
15	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2013
14	CaspasesIBA 01/2020 - 07/2007
13	MelatoninIBA 01/2021 - 08/2012
11	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2022 - 05/2014
7	Pharmaceutical PreparationsIBA 01/2021 - 09/2013
7	Cytochromes c (Cytochrome c)IBA 01/2018 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2014
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 01/2011
5	Biological ProductsIBA 01/2021 - 01/2013
5	Carrier Proteins (Binding Protein)IBA 01/2017 - 10/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2012
4	Dinoprostone (PGE2)FDA Link 10/2017 - 08/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 01/2012
3	Fluorouracil (Carac)FDA LinkGeneric 03/2022 - 03/2017
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
3	CateninsIBA 01/2020 - 01/2017
3	EnzymesIBA 01/2020 - 01/2016
3	LuciferasesIBA 02/2019 - 10/2014
3	Caspase 3 (Caspase-3)IBA 10/2017 - 01/2013
3	Messenger RNA (mRNA)IBA 10/2016 - 01/2011
2	Proto-Oncogene Proteins B-rafIBA 01/2021 - 02/2019
2	Epirubicin (Ellence)FDA LinkGeneric 01/2021 - 01/2021
2	VemurafenibIBA 01/2021 - 02/2019
2	Nuclear Receptor Coactivator 3IBA 11/2020 - 01/2018
2	Poly UIBA 01/2020 - 01/2020
2	RNA Splicing FactorsIBA 01/2020 - 01/2020
2	palbociclibIBA 10/2019 - 12/2015
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2019 - 11/2014
2	B7-H1 AntigenIBA 08/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 08/2017 - 01/2015
2	streptavidin-agaroseIBA 01/2017 - 01/2017
2	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2017 - 04/2016
2	CREB-Binding ProteinIBA 01/2017 - 02/2016
2	Biotin (Vitamin H)FDA Link 01/2017 - 10/2014
2	Sirolimus (Rapamycin)FDA Link 05/2016 - 07/2014
2	BerberineIBA 01/2016 - 01/2013
2	ChromatinIBA 12/2014 - 10/2014
2	Ursolic AcidIBA 05/2013 - 01/2013
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 12/2021
1	Transfer RNA (tRNA)IBA 11/2021
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 11/2021
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	LigandsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	elemeneIBA 12/2020
1	NF-kappa B (NF-kB)IBA 12/2020
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 10/2020
1	Aurora Kinase AIBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	Untranslated Regions (Untranslated Region)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	human ERBB2 proteinIBA 10/2019
1	pyrotinibIBA 10/2019
1	Therapeutic UsesIBA 10/2019
1	Pemetrexed (MTA)FDA Link 04/2019
1	icotinibIBA 04/2019
1	Epithelial Cell Adhesion MoleculeIBA 02/2019
1	PanobinostatIBA 01/2019
1	Cyclin D1IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019

Therapy/Procedure

15	Therapeutics 01/2021 - 01/2013
9	Drug Therapy (Chemotherapy) 01/2020 - 01/2012
7	Radiotherapy 12/2020 - 01/2013
3	Immunotherapy 04/2022 - 01/2020
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 08/2016 - 12/2015